The new Ananta campus marks a significant milestone in our journey, marking the technological paradigm shift underway ... partnership with India’s vibrant research and startup ecosystem, while ...

Courtesy of New Paradigm Following BlueMTec, a representative nurturing corporation that successfully went public (IPO) at the end of 2023, Medical AI, invested in by the 1st fund, has selected ...

IPO GMP Live: Quality Power day 3 subscription ... Additionally, the company has strong research and development capabilities, enabling it to offer future-ready solutions. The management team ...

Some tech companies are delaying or pulling their listing plans as the Trump administration’s tariff announcements and other changes cause market volatility and uncertainty. By Erin Griffith ...

The initial public offering (IPO) of Quality Power Electrical Equipments continued to attract a mixed response from the investors during the second day of the bidding process from all the ...

Shardul Amarchand Mangaldas & Co (SAM) and JSA are advising Veeda Clinical Research Limited on its proposed IPO, comprising a ₹185 crore fresh issue and an offer for sale of up to 13,008,128 equity ...

An increase in initial public offerings (IPOs) and a resulting uptick in market activity would provide pension funds with viable investment opportunities amid record asset growth. With domestic ...

senior research analyst at Renaissance Capital, a provider of pre-IPO research and IPO-focused ETFs. Investors are awaiting more policy clarity as President Donald Trump's administration takes ...

encourages research and development and promotes carbon trading through a dedicated registry. These measures align with the UAE’s 2050 net-zero ambitions and are likely to influence IPO market ...

Clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis—Sionna Therapeutics (SION) priced its upsized initial public offering of ...